Anthem Biosciences Gains 3.70%: 5 Key Factors Driving the Week’s Rally

1 hour ago
share
Share Via
Anthem Biosciences Ltd delivered a solid weekly gain of 3.70% from Rs.900.60 to Rs.933.90 between 31 August and 4 September 2026, outperforming the Sensex which declined by 1.11% over the same period. The stock demonstrated resilience amid a broadly bearish market, hitting multiple new 52-week and all-time highs, supported by strong technical momentum and sustained buying interest despite some short-term financial softness.

Key Events This Week

31 Aug: Stock opens week at Rs.891.50, down 1.01%

1 Sep: Intraday high of Rs.936.95, 5.09% surge

2 Sep: New 52-week and all-time high at Rs.951.6

3 Sep: New 52-week and all-time high at Rs.954.6

4 Sep: New 52-week and all-time high at Rs.970.8

Week Open
Rs.900.60
Week Close
Rs.933.90
+3.70%
Week High
Rs.970.80
vs Sensex
+4.81%

31 August 2026: Week Begins with a Slight Decline

Anthem Biosciences Ltd started the week at Rs.891.50, down 1.01% from the previous close, mirroring the broader market weakness as the Sensex fell 0.48% to 36,615.95. The stock traded on relatively high volume of 161,927 shares, indicating active participation despite the decline. This initial dip set the stage for a strong rebound in the following sessions.

1 September 2026: Strong Intraday Surge Near 52-Week High

On 1 September, the stock rebounded sharply, closing at Rs.923.15, a gain of 3.55% on the day. It reached an intraday high of Rs.936.95, just 0.58% below its 52-week peak of Rs.942. This 5.09% intraday surge marked a significant reversal after two days of declines and outperformed the Sensex, which fell 0.30%. The stock’s technical indicators remained bullish, trading above all key moving averages and supported by positive momentum signals such as MACD and KST on weekly charts.

2 September 2026: New 52-Week and All-Time High at Rs.951.6

Anthem Biosciences Ltd achieved a new milestone on 2 September, hitting an all-time high of Rs.951.6 during the session and closing at Rs.933.85, up 1.16%. This marked the second consecutive day of gains, with a cumulative return of 6.26% over two days. The stock outperformed its Pharmaceuticals & Biotechnology sector by 2.96% and the Sensex, which declined 0.44%. Technical momentum remained strong with bullish MACD and Bollinger Bands on weekly charts, although some indicators like RSI and OBV showed neutral trends, suggesting consolidation potential.

3 September 2026: Continued Momentum with New Highs

The rally extended on 3 September as Anthem Biosciences Ltd reached a new 52-week high of Rs.954 and an all-time high of Rs.954.60, closing at Rs.949.55, a 1.68% gain. This marked three consecutive days of gains, delivering a cumulative 7.01% return. Despite the Sensex closing marginally lower by 0.08%, the stock outperformed its sector by 2.31%. Technical indicators upgraded the momentum from mildly bullish to bullish, supported by strong MACD, Bollinger Bands, and KST signals. The stock traded comfortably above all major moving averages, reinforcing the sustained upward trend.

Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!

  • - Rigorous evaluation cleared
  • - Expert-backed selection
  • - Mid Cap conviction pick

See Expert Backing →

4 September 2026: New 52-Week and All-Time High at Rs.970.8

On the final trading day of the week, Anthem Biosciences Ltd reached a fresh 52-week and all-time high of Rs.970.8, opening with a gap up and signalling strong buying interest. The stock closed slightly lower at Rs.933.90, down 1.65% on the day, but maintained its position above all key moving averages. The Sensex gained 0.19% on the day but remained below its 50-day moving average, highlighting the stock’s relative strength. The company’s Mojo Score remained steady at 64.0 with a Hold rating, reflecting a balanced view amid strong technical momentum and some caution due to short-term financial softness.

Why settle for Anthem Biosciences Ltd? SwitchER evaluates this mid-cap against peers, other sectors, and market caps to find you superior investment opportunities!

  • - Comprehensive evaluation done
  • - Superior opportunities identified
  • - Smart switching enabled

Discover Superior Stocks →

Daily Price Comparison: Anthem Biosciences Ltd vs Sensex

Date Stock Price Day Change Sensex Day Change
2026-08-31 Rs.891.50 -1.01% 36,615.95 -0.48%
2026-09-01 Rs.923.15 +3.55% 36,506.61 -0.30%
2026-09-02 Rs.933.85 +1.16% 36,344.55 -0.44%
2026-09-03 Rs.949.55 +1.68% 36,315.81 -0.08%
2026-09-04 Rs.933.90 -1.65% 36,385.87 +0.19%

Key Takeaways from the Week

Positive Signals: Anthem Biosciences Ltd demonstrated strong relative strength by gaining 3.70% for the week while the Sensex declined 1.11%. The stock hit multiple new 52-week and all-time highs, supported by bullish technical indicators including MACD, Bollinger Bands, and moving averages across daily, weekly, and monthly timeframes. The sustained trading above key moving averages and consistent outperformance of the Pharmaceuticals & Biotechnology sector highlight robust momentum and investor confidence.

Cautionary Notes: Despite strong price gains, some technical indicators such as RSI and OBV showed neutral or mixed signals, suggesting potential consolidation phases. Short-term financial results revealed softness in quarterly profit before tax and net sales, indicating some pressure on earnings. The Mojo Score of 64.0 with a Hold rating reflects a balanced view, signalling moderate confidence but advising caution amid evolving market conditions.

Conclusion

Anthem Biosciences Ltd’s performance during the week of 31 August to 4 September 2026 was marked by notable resilience and strength amid a broadly weak market. The stock’s ability to set new 52-week and all-time highs, combined with sustained technical momentum and relative outperformance of the Sensex and sector peers, underscores its robust market positioning. While short-term financial softness and mixed volume indicators counsel prudence, the overall trajectory remains positive. The Hold rating and Mojo Score reflect a balanced outlook, suggesting that the stock is maintaining strength but may experience periods of consolidation as it navigates current market dynamics.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News